December 10th & 11th, 2026
15th edition
MARSEILLE, FR
Linkedin
0 items0 items0 items

News

Discover the BioFIT 2018 preliminary conference programme!

News /

The BioFIT Steering Committee is glad to announce the BioFIT 2018 preliminary conference programme:

 

PLENARY SESSION: Seed funds crossing borders: How far and how fast is the early-stage investment market in Biotech globalising?

Globalisation of seed investment can be seen as traditionally geographically anchored, now early-stage investors tend to invest in more diversified areas. Where does the money come from? How far is this evolution towards more global funds going? How fast is it going in the investment community? Will it make the investors more risk taking, will it change the risk landscape? Isn’t there today an ill-balance between the geographical origin of the investment capacities and the areas where projects needing equity investment are teeming?[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]

TRACK 1: Best practices in academia-industry R&D collaborations

  • Artificial Intelligence to speed-up drug discovery: The revolutionary road to advance innovation.
  • A prospective overview of the forthcoming cross-sectorial collaborations and licensing deals between human and animal health
  • Beyond shared means, common strategies to collectively succeed
  • Patient organisations to join the pharma-biotech-academia trio: Is a fourth musketeer calling for a new way to manage alliances?
Interested in joining a panel?

TRACK 2: Nurturing and licensing early-stage assets

  • What is the right balance between equity, royalties, collaborative research income for the academic institutions in the process of spinning out companies?
  • An overview of the recent joint initiatives to derisk academic-origin assets
  • Questioning TTOs financing models: Could their expected financial outcome bias the tech transfer process?
  • Under pressure: How does the urge to bring rare disease therapies create a new range of business models or collaborative models?
Interested in joining a panel?

TRACK 3: Early-stage innovation: Identify the right funding sources

  • Are philanthropic and alternative sources of soft funding always a free lunch?
  • Shaping your start-up for an industrial exit or an IPO: Are there choices to be made at the very initial stage?
  • Are immunotherapies a new investment Eldorado?
  • Agnostic or pure players in the biotech sector: Who is getting prominent in the early-stage financing rounds?
Interested in joining a panel?

Discover the BioFIT 2018 preliminary conference programme! Read More »

Conference insight

News /

Conference insight – Shaping your start-up for an industrial exit or an IPO: Are these choices to be made at the very initial stage?

4 Dec 2018  4:00 – 6:00 pm

Decisions taken at the very initial stage have major consequences for the future development of start-ups with major pitfalls to be avoided. Is it crucial to picture the exit strategy as soon as the company is created? The session relies on its panellists’ stories to go over different approaches of IPO and exits for start-ups.

They will share their experiences:

  • Lucie Ellis, Senior Editor, Pharma Intelligence | Informa (UK) – Moderator
  • Peter Leonardi, CEO, OmniCyte (US)
  • George Hoffman, Co-founder and CEO, Network Immunology (US)
  • Rodolphe Besserve, Head SuFT Advisory, Start-upd & French Techs, Société Générale Corporate Investments and and Banking (FR)
Discover the BioFIT 2018 conference programme

 

Conference insight Read More »

Call for applications

News /

Apply for the presentation sessions! 

> Promote your innovations

> Receive a speed-monitoring from pharma, biotech, TTO and investors

> Find partners who could support your project

Are you an entrepreneur who has created an innovative company (less than 5 years old or to be created)?

Apply for the Start-up Slams!

  1. Apply before 30th June: Dedicated to entrepreneurs who have created an innovative company (less than 5 years old or to be created)
  2. Be selected: A jury of experts will select the most innovative projects
  3. Exhibit: The selected candidates will benefit from a space at BioFIT to hold their one-to-one meetings
  4. Pitch: A 6-7 minute presentation of each selected project to potential partners and investors during bioFIT
  5. Receive a speed-mentoring: A jury composed of pharma and investors will give feeback and advice to the presenters
  6. Be awarded: The most innovative start-up will be awarded by the jury of experts of BioFIT
Apply for the Start-up Slams now

Are you a tech transfer officer with a ready-to-be-licensed technology?

Apply for the Licensing Opportunity Presentations!

  1. Apply: Dedicated to TTO, universities or related structures that have ready-to-be-licensed technologies
  2. Be selected: A jury of experts will select the most innovative technologies
  3. Exhibit: The selected candidates will benefit from a poster’s exhibition at BioFIT describing their out-licensing opportunities
  4. Pitch: Presentations of the selected projects to potential industrial partners during BioFIT
  5. Find partners: The presenters can easily find industrial partners who could in-license their assets
Apply for the Licensing Opportunity Presentations now

Call for applications Read More »

Come hear them speak at BioFIT 2018!

News /

They will speak at BioFIT 2018:

  • Jan Adams, Managing Director, EMBL Ventures (DE)
  • Anjan Aralihalli, Venture Partner, CTI Life Sciences Fund II (CA)
  • Caroline Barelle, CEO, Elasmogen (UK)
  • Yann Barrault, Head of Business Development & Licensing, SATT Grand Centre (FR)
  • Jean-Charles Brosse, Partner Healthcare & Life Sciences, Positive Capital (FR)
  • Alain Chevallier, Life Sciences Partner, Truffle Capital (FR)
  • Lucie Ellis, Senior Editor, Pharma Intelligence | Informa (UK)
  • Juan Garcia, CEO, BioSeed Capital (ES)
  • George Hoffman, Co-founder and CEO, Network Immunology (US)
  • Adrian Ibrahim, Head of Technology Transfer, Wellcome Sanger Institute (UK)
  • Steven J. Klein, Vice President, Business Development, IRICoR – Institute for Research in Immunology and Cancer-Commercialization of Research (CA)
  • Peter Leonardi, CEO, OmniCyte (US)
  • Michael Motz, CBO, NETRIS Pharma (FR)
  • Michael L. Salgaller, Supervisor, Invention Development and Marketing Unit, National Institutes of Health (NIH) | National Cancer Institute (NCI) | Technology Transfer Center (US)
  • Bernd Stowasser, Head of Alliance Management Germany & Global Public Private Partnerships, Sanofi (DE)
  • Jonathan Tobin, Investment Director, Arix Bioscience (UK)
  • Ewa Truchanowicz, Life Sciences Lead, University of Birmingham Enterprise (UK)
  • Bram Vanparys, Investment Director, MS Ventures (NL)
Want to join them?
Discover the conference programme

Come hear them speak at BioFIT 2018! Read More »

We are very honoured to count Boehringer Ingelheim among the Sponsors of BioFIT 2018

News /

Many thanks to Boehringer Ingelheim for joining BioFIT 2018 as a Bronze Sponsor!

Innovative medicines for people and animals have for more than 130 years been what the research-driven pharmaceutical company Boehringer Ingelheim stands for. Boehringer Ingelheim  is one of the pharmaceutical industry’s top 20 companies and to this day remains family-owned. Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing.

Join this key BioFIT 2018 sponsor to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

For more information about the sponsorship opportunities, visit the dedicated site page.

We are very honoured to count Boehringer Ingelheim among the Sponsors of BioFIT 2018 Read More »

We are very honoured to count Roche among the Sponsors of BioFIT 2018

News /

Many thanks to Roche for joining BioFIT 2018 as a Bronze Sponsor!

As a pioneer in healthcare, Roche has been committed to improving lives since the company was founded in 1896. Today, Roche creates innovative medicines and diagnostics tests for millions of patients.

Join this key BioFIT 2018 sponsor to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

They were the BioFIT 2017 sponsors: Sanofi, Pfizer, Bayer, Genfit, Lilly, MSD, Merck, Boehringer Ingelheim, Johnson & Johnson Innovation, Novo Nordisk, LFB, PPRS and Trianni.

For more information about the sponsorship opportunities, visit the dedicated site page.

We are very honoured to count Roche among the Sponsors of BioFIT 2018 Read More »

[VIDEO] They were at #BioFIT2017: Future Worlds

News /

After an exciting and successful first day at BioFIT 2017, the Future Worlds team arrived early on Wednesday morning at the Palais de la Musique et des Congrès convention centre, ready for another energetic day at Europe’s leading life sciences partnering event in Strasbourg. After filming some footage for the blog of the buzzing convention centre, Brigitte and I interviewed our resident stand spinout Dr Agnieszka Janeczek of Renovos in our second …

Read the whole article on FuturaWorlds.com

Watch the video made by Future Worlds:

Future Worlds is a startup platform and business incubator championing the innovative commercial opportunities being developed by researchers and students at the University of Southampton.

[VIDEO] They were at #BioFIT2017: Future Worlds Read More »

Scroll to Top
Cart Have a coupon ?
  • No products in the cart.
Cart - €0.00
  • 0
  • 1